Edition:
United States

Leap Therapeutics Inc (LPTX.OQ)

LPTX.OQ on NASDAQ Stock Exchange Global Market

3.20USD
3:59pm EST
Change (% chg)

$0.03 (+0.95%)
Prev Close
$3.17
Open
$3.12
Day's High
$3.36
Day's Low
$3.11
Volume
8,570
Avg. Vol
11,337
52-wk High
$10.25
52-wk Low
$3.11

Chart for

About

Leap Therapeutics, Inc., formerly HealthCare Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company engages in acquiring and developing therapeutics in cancer biology. Its lead product candidates for use in clinical trials include TRX518 and DKN-01. DKN-01 is a monoclonal antibody targeting Dickkopf-re... (more)

Overall

Beta: --
Market Cap(Mil.): $52.78
Shares Outstanding(Mil.): 14.70
Dividend: --
Yield (%): --

Financials

  LPTX.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -3.45 -- --
ROI: -260.28 0.60 13.80
ROE: -466.82 -2.18 15.29

Earnings vs. Estimates